Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.60 +5.23 (+4.61%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
40 41 Next >
Stranger Things Do Happen As Netflix Surprises Investors
(Wednesday Market Open) The European Commission (EU) has asked its 27 member nations to reduce their natural gas consumption by 15% between August and March 2023. The announcement turned U.S. equity... 
Via Benzinga
Abbott Laboratories (ABT) Stock Slides Despite Q2 Earnings Beat
Abbott Laboratories (ABT) stock is falling on Wednesday despite posting a positive earnings report for the second quarter of 2022. 
Via InvestorPlace
Abbott Lifts Annual Profit Guidance On Higher COVID-19 Test Sales
Via Benzinga
What's Going On With Abbott Stock Today?
Abbott Laboratories (NYSE: ABT) shares are trading lower Wednesday after the company reported financial results. 
Via Benzinga
Abbott's Deep Brain Stimulation Receives FDA's Breakthrough Device Tag To Manage Depression
Via Benzinga
Abbott Reopens Its Michigan Plant Closed Due To Floods: Report
Via Benzinga
Recap: Abbott Laboratories Q2 Earnings
  Abbott Laboratories (NYSE:ABT) reported its Q2 earnings results on Wednesday, July 20, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Abbott Laboratories Posts Better-Than-Expected Q2 Sales, Earnings
Abbott Laboratories topped estimates for second-quarter sales and earnings and guided higher for the full year. But ABT stock dipped. 
Via Investor's Business Daily
Investors Turn Their Attention To The Earning Season
US stock indices rose on Tuesday as investors temporarily put aside recession fears and dived into the reporting season. 
Via Talk Markets
Market Volatility Subsides Following Tuesday's Surge In Stocks
U.S. markets recorded sharp gains on Tuesday, with the S&P 500 notching the highest close since June 9. All the major sectors in the S&P 500 settled higher on Tuesday, with industrials and... 
Via Benzinga
Investor Fear Eases On Upbeat Corporate Earnings
Although the CNN Money Fear and Greed index showed US equity markets remained in the "fear" zone on Wednesday, but it saw some significant easing in the overall fear level amid a sharp rise on the Wall... 
Via Benzinga
U.S. Stock Futures Edge Higher; Tesla Earnings In Focus
Pre-open movers 
Via Benzinga
Earnings Scheduled For July 20, 2022
Companies Reporting Before The Bell • Wipro (NYSE:WIT) is projected to report quarterly earnings at $0.08 per share on revenue of $2.80 billion. 
Via Benzinga
Tesla, Abbott Laboratories And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading higher this morning on Wednesday ahead of earnings reports from several companies, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Bitcoin Now Surges Past This Major Level, Here Are Other Crypto Movers That Should Be On Your Radar
The cryptocurrency market continued to recover on Wednesday, with Bitcoin (CRYPTO: BTC), the world’s oldest cryptocurrency, surpassing the $23,000 level. 
Via Benzinga
Apple Upstages Goldman Sachs On Monday, Bringing Rally To A Screeching Halt
(Tuesday Market Open) A big slide in the U.S. dollar appears to be pushing stocks higher Tuesday as a slew of earnings arrived before the opening bell. 
Via Benzinga
Preview: Abbott Laboratories's Earnings
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-07-20. Here's what investors need to know before the announcement. Analysts estimate that Abbott... 
Via Benzinga
Bank Of America And Goldman Sachs Split On Earnings Reports, Possibly Putting Bank Rally In Jeopardy
(Monday Market Open) Investors around the globe appear to be starting the new trading week with a positive attitude as Asian and European markets traded higher overnight helping to boost U.S. equity... 
Via Benzinga
Abbott Labs Stock Can Be a Recession Hedge for Your Portfolio
Diversified global medical science products maker Abbott (NYSE: ABT) stock is down a modest (-11.5%) on the year. Abbott provides full lifecycle health and medical products from baby formula to... 
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy Product Safety
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Abbott Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Abbott Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
7 Analysts Have This to Say About Abbott Laboratories
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Another Way To Understand Market Momentum
(Friday Market Open) U.S. equity futures moved higher early Friday as investors digested better-than-expected June retail sales data and China’s worst GDP numbers since the start of the pandemic. Later... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Hot Inflation And Earnings Misses Weigh On Equity Futures
(Thursday Market Open) The equity markets may take another hit today as JPMorgan Chase (NYSE: JPM) and Morgan Stanley (NYSE: MS) kicked off a new earnings season with a couple of misses as eq 
Via Benzinga
The Fed's Pickle: Whether to Raise Rates to Fight Inflation While Increasing Recession Chances
(Wednesday Market Open) The June Consumer Price Index (CPI) came in much hotter than expected, and equity index futures tumbled before the open.  
Via Benzinga
Analyzing Abbott Laboratories's Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 7.41% since its last report. The company recently reported that it has 12.98 million shares sold short, which is... 
Via Benzinga
5 Dividend Kings That Income Investors Can Count On
Dividend Kings are usually looked at as a safer bet than other investments because it gives you stable income during market volatility. 
Via InvestorPlace
Abbott Gets FDA Breakthrough Device Status For Depression Therapy System
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to investigate the use of Abbott’s (NYSE: ABT) deep brain stimulation (DBS) system in treatment-resistant... 
Via Benzinga
$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.16% on an annualized basis producing an average annual return of 13.1%. Currently, Abbott Laboratories has a... 
Via Benzinga
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.